Bobby Ivan Griffin

Envoy Medical Corp. manufactures surgical instrumentation and diagnostic equipment for implantable hearing systems. The company was founded in 1995 and is headquartered in Minneapolis, MN.

MTS Systems Corp. engages in the provision of test systems and sensors. It operates through the Test & Simulation and Sensors segments. The Test & Simulation segment provides testing and simulation solutions including hardware, software and services that are used by customers in product development to characterize a product's mechanical properties along with simulation systems for human response features. The Sensors segment focuses on sensors used for measurement of vibration, pressure, position, force, and sound. The company was founded in 1966 and is headquartered in Eden Prairie, MN.

CoAxiaTM was a development stage, private, venture-backed medical device company in clinical trials with an innovative, catheter-based therapy for the treatment of cerebral ischemia, most notably: ischemic stroke. CoAxia's business focus was demonstrating the safety and efficacy of its NeuroFlo™ catheter and making it a standard treatment option hundreds of thousands of stroke patients worldwide. In addition, CoAxia was in limited distribution of NeuroFlo to treat cerebral vasospasm, under an HDE market approval from the FDA. CoAxia holds several key patents on the concept and implementation of cerebral perfusion augmentation as well as numerous other patents relevant to various vascular disorders. CoAxia was founded in 1999 by Denise Barbut MD.

Transneuronix, Inc. used to develop and manufacture medical devices. The company was designed implantable pacemaker for the treatment of obesity, neurological disfunctioning and other medical accessories. Transneuronix, Inc. was founded in 1995 and was headquartered in Mount Arlington, NJ.

Salient Surgical Technologies, Inc. designs, develops, and markets disposable surgical devices. The company was founded in 1999 and is headquartered in Minneapolis, MN.

ValenTx, Inc. develops therapy solutions. It operates as a medical device company. The firm's therapy solutions focus on treating type-2 diabetes and hypertension. The company was founded by Mitchell Dann in June 2002 and is headquartered in Maple Grove, MN.

EnteroMedics, Inc. is a medical device company, which in the design, and development of devices that use neuroblocking technology to treat obesity,metabolic diseases, and other gastrointestinal disorders. It offers vBlock system, which is a therapy to limit expansion of hte stomach, help control hunger sensations between meals, reduce the frequency and intensity of stomach contractions and produce a feeling of early and prolonged fullness. The company was founded by Mark B. Knudson, Robert S. Nickoloff, Timothy R. Conrad, Katherine S. Tweden and Richard R. Wilson on December 19, 2002 and is headquartered in St. Paul, MN.